157 related articles for article (PubMed ID: 36564469)
1. ATX-101, a cell-penetrating protein targeting PCNA, can be safely administered as intravenous infusion in patients and shows clinical activity in a Phase 1 study.
Lemech CR; Kichenadasse G; Marschner JP; Alevizopoulos K; Otterlei M; Millward M
Oncogene; 2023 Feb; 42(7):541-544. PubMed ID: 36564469
[TBL] [Abstract][Full Text] [Related]
2. Targeting proliferating cell nuclear antigen and its protein interactions induces apoptosis in multiple myeloma cells.
Müller R; Misund K; Holien T; Bachke S; Gilljam KM; Våtsveen TK; Rø TB; Bellacchio E; Sundan A; Otterlei M
PLoS One; 2013; 8(7):e70430. PubMed ID: 23936203
[TBL] [Abstract][Full Text] [Related]
3. PCNA regulates primary metabolism by scaffolding metabolic enzymes.
Røst LM; Ræder SB; Olaisen C; Søgaard CK; Sharma A; Bruheim P; Otterlei M
Oncogene; 2023 Feb; 42(8):613-624. PubMed ID: 36564470
[TBL] [Abstract][Full Text] [Related]
4. ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma.
Gravina GL; Colapietro A; Mancini A; Rossetti A; Martellucci S; Ventura L; Di Franco M; Marampon F; Mattei V; Biordi LA; Otterlei M; Festuccia C
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053455
[TBL] [Abstract][Full Text] [Related]
5. Increased Anticancer Efficacy of Intravesical Mitomycin C Therapy when Combined with a PCNA Targeting Peptide.
Gederaas OA; Søgaard CD; Viset T; Bachke S; Bruheim P; Arum CJ; Otterlei M
Transl Oncol; 2014 Dec; 7(6):812-23. PubMed ID: 25500092
[TBL] [Abstract][Full Text] [Related]
6. A novel cell permeable DNA replication and repair marker.
Herce HD; Rajan M; Lättig-Tünnemann G; Fillies M; Cardoso MC
Nucleus; 2014; 5(6):590-600. PubMed ID: 25484186
[TBL] [Abstract][Full Text] [Related]
7. A site-selective, irreversible inhibitor of the DNA replication auxiliary factor proliferating cell nuclear antigen (PCNA).
Evison BJ; Actis ML; Wu SZ; Shao Y; Heath RJ; Yang L; Fujii N
Bioorg Med Chem; 2014 Nov; 22(22):6333-43. PubMed ID: 25438756
[TBL] [Abstract][Full Text] [Related]
8. Targeting Proliferating Cell Nuclear Antigen (PCNA) as an Effective Strategy to Inhibit Tumor Cell Proliferation.
Cardano M; Tribioli C; Prosperi E
Curr Cancer Drug Targets; 2020; 20(4):240-252. PubMed ID: 31951183
[TBL] [Abstract][Full Text] [Related]
9. NKp44-Derived Peptide Binds Proliferating Cell Nuclear Antigen and Mediates Tumor Cell Death.
Shemesh A; Kundu K; Peleg R; Yossef R; Kaplanov I; Ghosh S; Khrapunsky Y; Gershoni-Yahalom O; Rabinski T; Cerwenka A; Atlas R; Porgador A
Front Immunol; 2018; 9():1114. PubMed ID: 29875773
[TBL] [Abstract][Full Text] [Related]
10. Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis.
Sun Z; Jha HC; Robertson ES
J Virol; 2015 Oct; 89(20):10206-18. PubMed ID: 26223641
[TBL] [Abstract][Full Text] [Related]
11. Lys-110 is essential for targeting PCNA to replication and repair foci, and the K110A mutant activates apoptosis.
Kim BJ; Lee H
Biol Cell; 2008 Dec; 100(12):675-86. PubMed ID: 18498247
[TBL] [Abstract][Full Text] [Related]
12. Validating the disruption of proliferating cell nuclear antigen interactions in the development of targeted cancer therapeutics.
Smith SJ; Hickey RJ; Malkas LH
Cancer Biol Ther; 2016; 17(3):310-9. PubMed ID: 26889573
[TBL] [Abstract][Full Text] [Related]
13. PCNA-Dependent Cleavage and Degradation of SDE2 Regulates Response to Replication Stress.
Jo U; Cai W; Wang J; Kwon Y; D'Andrea AD; Kim H
PLoS Genet; 2016 Dec; 12(12):e1006465. PubMed ID: 27906959
[TBL] [Abstract][Full Text] [Related]
14. The Anticancer Activity of a First-in-class Small-molecule Targeting PCNA.
Gu L; Lingeman R; Yakushijin F; Sun E; Cui Q; Chao J; Hu W; Li H; Hickey RJ; Stark JM; Yuan YC; Chen Y; Vonderfecht SL; Synold TW; Shi Y; Reckamp KL; Horne D; Malkas LH
Clin Cancer Res; 2018 Dec; 24(23):6053-6065. PubMed ID: 29967249
[TBL] [Abstract][Full Text] [Related]
15. Structural and Functional Insight into Proliferating Cell Nuclear Antigen.
Park SY; Jeong MS; Han CW; Yu HS; Jang SB
J Microbiol Biotechnol; 2016 Apr; 26(4):637-47. PubMed ID: 26699741
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of DNA replication by an anti-PCNA aptamer/PCNA complex.
Kowalska E; Bartnicki F; Fujisawa R; Bonarek P; Hermanowicz P; Tsurimoto T; Muszynska K; Strzalka W
Nucleic Acids Res; 2018 Jan; 46(1):25-41. PubMed ID: 29186524
[TBL] [Abstract][Full Text] [Related]
17. Mediation of proliferating cell nuclear antigen (PCNA)-dependent DNA replication through a conserved p21(Cip1)-like PCNA-binding motif present in the third subunit of human DNA polymerase delta.
Ducoux M; Urbach S; Baldacci G; Hübscher U; Koundrioukoff S; Christensen J; Hughes P
J Biol Chem; 2001 Dec; 276(52):49258-66. PubMed ID: 11595739
[TBL] [Abstract][Full Text] [Related]
18. Regulation of DNA replication and repair proteins through interaction with the front side of proliferating cell nuclear antigen.
Jónsson ZO; Hindges R; Hübscher U
EMBO J; 1998 Apr; 17(8):2412-25. PubMed ID: 9545252
[TBL] [Abstract][Full Text] [Related]
19. PCNA on the crossroad of cancer.
Stoimenov I; Helleday T
Biochem Soc Trans; 2009 Jun; 37(Pt 3):605-13. PubMed ID: 19442257
[TBL] [Abstract][Full Text] [Related]
20. Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation.
Strzalka W; Ziemienowicz A
Ann Bot; 2011 May; 107(7):1127-40. PubMed ID: 21169293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
